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2010-2011 Influenza Season 
Week 47 ending November 27, 2010 
All data are preliminary and may change as more reports are received. 
 
Synopsis: During week 47 (November 21-27, 2010), influenza activity in the United States 
remained relatively low overall, but increased slightly in the Southeast. 
o Of the 3,430 specimens tested by U.S. World Health Organization (WHO) and National 
Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and 
reported to CDC/Influenza Division, 366 (10.7%) were positive for influenza. 
o The proportion of deaths attributed to pneumonia and influenza (P&I) was below the 
epidemic threshold.  
o No influenza-associated pediatric deaths were reported.  
o The proportion of outpatient visits for influenza-like illness (ILI) was 1.9%, which is below the 
national baseline of 2.5%. One of the 10 regions (Region 4) reported ILI above region-
specific baseline levels; one state experienced high ILI activity; one state experienced low 
ILI activity, and 48 states experienced minimal ILI activity. 
o The geographic spread of influenza in one state was reported as regional, Puerto Rico and 
nine states reported local activity; the District of Columbia, Guam, the U.S. Virgin Islands, 
and 33 states reported sporadic activity; and seven states reported no influenza activity. 
 
National and Regional Summary of Select Surveillance Components 
 Data for current week Data cumulative since October 3, 2010 (Week 40) 
HHS 
Surveillance 
Regions* 
Out-
patient 
ILI† 
% 
positive 
for flu‡ 
Number of  
jurisdictions 
reporting 
regional or 
widespread 
activity§ 
A (H3) 2009 A (H1N1) 
A 
(Subtyping not 
performed) 
B Pediatric Deaths 
Nation Normal 10.7% 1 of 54 354 85 556 771 1 
Region 1 Normal 2.3% 0 of 6 13 2 1 1 0 
Region 2 Normal 4.3% 0 of 4 20 0 23 2 0 
Region 3 Normal 2.7% 0 of 6 26 16 3 2 0 
Region 4 Elevated 19.3% 1 of 8 124 21 406 680 0 
Region 5 Normal 3.5% 0 of 6 30 3 1 0 0 
Region 6 Normal 3.4% 0 of 5 23 1 49 33 1 
Region 7 Normal 0.4% 0 of 4 2 1 3 3 0 
Region 8 Normal 4.6% 0 of 6 64 15 49 6 0 
Region 9 Normal 2.2% 0 of 5 37 25 17 40 0 
Region 10 Normal 2.8% 0 of 4 15 1 4 4 0 
 
*HHS regions (Region 1 CT, ME, MA, NH, RI, VT; Region 2: NJ, NY, Puerto Rico, U.S. Virgin Islands; Region 3: DE, DC, MD, PA, VA, WV; Region 4: AL, FL, GA, KY, MS, NC, 
SC, TN; Region 5: IL, IN, MI, MN, OH, WI; Region 6: AR, LA, NM, OK, TX; Region 7: IA, KS, MO, NE; Region 8: CO, MT, ND, SD, UT, WY; Region 9: AZ, CA, Guam, HI, NV; 
and Region 10: AK, ID, OR, WA). 
† Elevated means the % of visits for ILI is at or above the national or region-specific baseline. 
‡ National data are for current week; regional data are for the most recent three weeks. 
§ Includes all 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands. 
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U.S. Virologic Surveillance: WHO and NREVSS collaborating laboratories located in all 50 states 
and Washington D.C. report to CDC the number of respiratory specimens tested for influenza and 
the number positive by influenza type and subtype. The results of tests performed during the 
current week are summarized in the table below. 
 
 Week 47 
No. of specimens tested 3,430 
No. of positive specimens (%) 366 (10.7%) 
Positive specimens by type/subtype  
Influenza A 181 (49.5%) 
          A (2009 H1N1)   7 (3.9%)  
          A (subtyping not performed)          47 (26.0%)
          A (H3)                127 (70.2%)  
Influenza B 185 (50.5%) 
 
The District of Columbia and 44 states from all 10 surveillance regions have reported laboratory-
confirmed influenza this season.  Region 4 in the Southeastern United States has accounted for 
1,231 (69.7%) of all 1,766 reported influenza viruses this season, including 680 (88.2%) of the 771 
influenza B viruses. 
 
Influenza Positive Tests Reported to CDC by U.S. WHO/NREVSS 
Collaborating Laboratories, National Summary, 2010-11 Season 
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Aggregate Hospitalization and Death Reporting Activity (AHDRA): This system tracks weekly 
counts of laboratory-confirmed influenza-associated hospitalizations and deaths and was 
implemented on August 30, 2009, during the 2009 pandemic, and ended on April 4, 2010. AHDRA 
surveillance during the 2010-11 season is being continued on a voluntary basis and 11 jurisdictions 
reported during week 47. From October 3-November 27, 2010, 271 laboratory-confirmed influenza 
associated hospitalizations and seven laboratory-confirmed influenza associated deaths were 
reported to CDC. 
  
Weekly Laboratory-Confirmed Influenza-Associated Hospitalizations and 
Deaths, National Summary, 2010-11 Season 
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Antigenic Characterization:  CDC has antigenically characterized 18 influenza viruses [four 2009 
influenza A (H1N1) viruses, eight influenza A (H3N2) viruses, and six influenza B viruses] collected 
by U.S. laboratories since October 1, 2010. 
 
2009 Influenza A (H1N1) [4] 
• All four were characterized as A/California/7/2009-like, the influenza A (H1N1) 
component of the 2010-11 influenza vaccine for the Northern Hemisphere. 
 
Influenza A (H3N2) [8] 
• All eight were characterized as A/Perth/16/2009-like, the influenza A (H3N2) 
component of the 2010-11 influenza vaccine for the Northern Hemisphere. 
 
Influenza B [6] 
 All six viruses belong to the B/Victoria lineage of viruses and were characterized as 
B/Brisbane/60/2008-like, the recommended influenza B component for the 2010-11 
Northern Hemisphere influenza vaccine. 
Antiviral Resistance: Testing of 2009 influenza A (H1N1), influenza A (H3N2), and influenza B 
virus isolates for resistance to neuraminidase inhibitors (oseltamivir and zanamivir) is performed at 
CDC using a functional assay. Additional 2009 influenza A (H1N1) clinical samples are tested for a 
single known mutation in the neuraminidase protein of the virus that confers oseltamivir resistance 
(H275Y). The data summarized below combine the results of both test methods and includes 
samples that were tested as part of routine surveillance purposes; it does not include diagnostic 
testing specifically done because of clinical suspicion of antiviral resistance. 
High levels of resistance to the adamantanes (amantadine and rimantadine) persist among 2009 
influenza A (H1N1) and A (H3N2) viruses (the adamantanes are not effective against influenza B 
viruses) circulating globally. As a result of the sustained high levels of resistance, data from 
adamantane resistance testing are not presented weekly in the table below.     
Neuraminidase Inhibitor Resistance Testing Results  
on Samples Collected Since October 1, 2010. 
 Viruses tested (n) 
Resistant 
Viruses, 
Number (%) 
Viruses 
tested (n) 
Resistant 
Viruses, 
Number (%) 
Oseltamivir Zanamivir 
Seasonal 
Influenza A 
(H1N1) 
0 0 (0.0) 0 0 (0.0) 
Influenza A 
(H3N2) 10 0 (0.0) 10 0 (0.0) 
Influenza B 13 0 (0.0) 13 0 (0.0) 
2009 
Influenza A 
(H1N1) 
8 0 (0.0) 8 0 (0.0) 
 
To prevent the spread of antiviral resistant virus strains, CDC reminds clinicians and the public of 
the need to continue hand and cough hygiene measures for the duration of any symptoms of 
influenza, even while taking antiviral medications. Additional information on antiviral 
recommendations for treatment and chemoprophylaxis of influenza virus infection is available at 
http://www.cdc.gov/flu/antivirals/index.htm.    
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Pneumonia and Influenza (P&I) Mortality Surveillance: During week 47, 6.0% of all deaths 
reported through the 122-Cities Mortality Reporting System were due to P&I. This percentage was 
below the epidemic threshold of 7.2% for week 47. 
 
Pneumonia and Influenza Mortality for 122 U.S. Cities 
Week ending 11/27/2010 
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Influenza-Associated Pediatric Mortality: No influenza-associated pediatric deaths were reported 
to CDC during week 47. 
 
One death, associated with an influenza A virus for which the subtype was not determined, 
occurring during the 2010-2011 season has been reported. 
 
Number of Influenza-Associated Pediatric Deaths by Week of Death: 
2007-08 season to present 
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Influenza-Associated Hospitalizations: The Influenza Hospitalization Network (FluSurv-NET) 
conducts surveillance for population-based, laboratory-confirmed influenza-related hospitalizations 
in children (persons younger than 18 years) and adults. The network covers over 80 counties in the 
10 Emerging Infections Program (EIP) states (CA, CO, CT, GA, MD, MN, NM, NY, OR, and TN) 
and six additional states (ID, MI, OH, OK, RI and UT). FluSurv-NET estimated hospitalization rates 
will be updated every two weeks starting later this season. 
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Outpatient Illness Surveillance: Nationwide during week 47, 1.9% of patient visits reported 
through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) were due to 
influenza-like illness (ILI). This percentage is below the national baseline of 2.5%. 
 
Percentage of Visits for Influenza-like Illness (ILI) Reported by  
the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet), 
Weekly National Summary, September 30, 2007 – November 27, 2010 
0
1
2
3
4
5
6
7
8
9
%
 o
f V
is
its
 fo
r I
LI
   
Week
% ILI National Baseline
 
 
On a regional level, the percentage of outpatient visits for ILI ranged from 0.4% to 3.2% during 
week 47. One of the 10 regions (Region 4) reported a proportion of outpatient visits for ILI above 
their region-specific baseline levels.   
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Region 6 - AR, LA, NM, OK, TX
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Region 2 - NJ, NY, USVI
0
2
4
6
8
10
20
08
40
20
08
50
20
09
10
20
09
20
20
09
30
20
09
40
20
09
50
20
10
10
20
10
20
20
10
30
20
10
40
Week
%
 o
f V
is
its
 fo
r I
LI
  
Region 3 - DE, DC, MD, PA, VA, WV
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Region 4 - AL, FL, GA, KY, MS, NC, SC, TN
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Region 5 - IL, IN, MI, MN, OH, WI
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Region 7 - IA, KS, MO, NE
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Region 9 - AZ, CA, HI, NV
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0
2
4
6
8
10
20
08
40
20
08
50
20
09
10
20
09
20
20
09
30
20
09
40
20
09
50
20
10
10
20
10
20
20
10
30
20
10
40
Week
%
 o
f V
is
its
 fo
r I
LI
  
NOTE: Scales differ between regions
*Use of the regional baselines for state data is not appropriate. 
Baseline*% ILI
 
2010-11 Influenza Season – Week 47, ending November 27, 2010           
 
9
 
ILINet Activity Indicator Map: Data collected in ILINet are used to produce a measure of ILI 
activity* by state. Activity levels are based on the percent of outpatient visits in a state due to ILI 
and are compared to the average percent of ILI visits that occur during spring and fall weeks with 
little or no influenza virus circulation. Activity levels range from minimal, which would correspond to 
ILI activity from outpatient clinics being below the average, to high, which would correspond to ILI 
activity from outpatient clinics being much higher than the average.  Because the clinical definition 
of ILI is very general, not all ILI is caused by influenza; however, when combined with laboratory 
data, the information on ILI activity provides a clear picture of influenza activity in the United States. 
 
During week 47, the following ILI activity levels were experienced: 
 One state (Georgia) experienced high ILI activity.  While influenza-like illness is a non-
specific term and may be caused by a variety of organisms, the increase in ILI in Georgia 
has occurred at the same time as a significant increase in the number of laboratory 
confirmed influenza B virus infections. 
 New York City and one state (Alabama) experienced low ILI activity. 
 Forty-eight states experienced minimal ILI activity (Alaska, Arizona, Arkansas, California, 
Colorado, Connecticut, Delaware, Florida, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, 
Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, 
Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New 
York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, 
South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, 
West Virginia, Wisconsin, and Wyoming). 
 Data were insufficient to calculate an ILI activity level from the District of Columbia. 
 
Interactive web tool available at: http://gis.cdc.gov/grasp/fluview/main.html 
*This map uses the proportion of outpatient visits to health care providers for influenza-like illness to measure the ILI activity level within a state. It does not, 
however, measure the extent of geographic spread of flu within a state. Therefore, outbreaks occurring in a single city could cause the state to display high 
activity levels. 
Data collected in ILINet may disproportionately represent certain populations within a state, and therefore, may not accurately depict the full picture of 
influenza activity for the whole state. 
Data displayed in this map are based on data collected in ILINet, whereas the State and Territorial flu activity map are based on reports from state and 
territorial epidemiologists. The data presented in this map is preliminary and may change as more data is received. 
Differences in the data presented by CDC and state health departments likely represent differing levels of data completeness with data presented by the 
state likely being the more complete.  
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Geographic Spread of Influenza as Assessed by State and Territorial Epidemiologists: The 
influenza activity reported by state and territorial epidemiologists indicates geographic spread of 
influenza viruses, but does not measure the severity of influenza activity. 
 
During week 47, the following influenza activity was reported: 
 Regional influenza activity was reported by one state (Georgia) 
 Local influenza activity was reported by Puerto Rico and nine states (Alabama, Connecticut, 
Hawaii, Louisiana, Mississippi, New York, Oklahoma, Pennsylvania, and South Carolina). 
 Sporadic influenza activity was reported by the District of Columbia, Guam, the U.S. Virgin 
Islands, and 33 states (Alaska, Arizona, Arkansas, California, Colorado, Florida, Idaho, 
Illinois, Indiana, Kansas, Kentucky, Maryland, Massachusetts, Michigan, Minnesota, 
Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, North Carolina, 
Ohio, Oregon, Rhode Island, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, 
Wisconsin, and Wyoming). 
 No influenza activity was reported by seven states (Delaware, Iowa, Maine, Nebraska, North 
Dakota, South Dakota, and Vermont). 
 
 
 
A description of surveillance methods is available at: http://www.cdc.gov/flu/weekly/overview.htm 
Report prepared: December 3, 2010. 
 
 
